Zheng XX - Search Results

1

NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells.

Hu QD, Chen W, Yan TL, Ma T, Chen CL, Liang C, Zhang Q, Xia XF, Liu H, Zhi X, Zheng XX, Bai XL, Yu XZ, Liang TB. Hu QD, et al. Among authors: zheng xx. Cancer Lett. 2012 Dec 28;325(2):207-13. doi: 10.1016/j.canlet.2012.07.003. Epub 2012 Jul 7. Cancer Lett. 2012. PMID: 22781398

2

WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.

Liu H, Chen W, Liang C, Chen BW, Zhi X, Zhang S, Zheng X, Bai X, Liang T. Liu H, et al. Cancer Lett. 2015 Jun 1;361(2):218-25. doi: 10.1016/j.canlet.2015.03.001. Epub 2015 Mar 5. Cancer Lett. 2015. PMID: 25749422

3

Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.

Liu RR, Lv YS, Tang YX, Wang YF, Chen XL, Zheng XX, Xie SZ, Cai Y, Yu J, Zhang XN. Liu RR, et al. Among authors: zheng xx. Oncotarget. 2016 Apr 26;7(17):24348-60. doi: 10.18632/oncotarget.8324. Oncotarget. 2016. PMID: 27028999 Free PMC article.

4

Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway.

Lv Y, Liu R, Xie S, Zheng X, Mao J, Cai Y, Chen W. Lv Y, et al. Anticancer Drugs. 2017 Sep;28(8):861-868. doi: 10.1097/CAD.0000000000000527. Anticancer Drugs. 2017. PMID: 28628491

5

TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver transplantation.

Zhang Y, Liu Y, Chen H, Zheng X, Xie S, Chen W, Ji H, Zheng S. Zhang Y, et al. Am J Transl Res. 2017 Aug 15;9(8):3665-3675. eCollection 2017. Am J Transl Res. 2017. PMID: 28861157 Free PMC article.

6

USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy.

Ma T, Chen W, Zhi X, Liu H, Zhou Y, Chen BW, Hu L, Shen J, Zheng X, Zhang S, Zhang B, Li H, Liang T. Ma T, et al. Cancer Lett. 2018 Nov 1;436:129-138. doi: 10.1016/j.canlet.2018.08.010. Epub 2018 Aug 15. Cancer Lett. 2018. PMID: 30118840

7

MicroRNA-212 suppresses nonsmall lung cancer invasion and migration by regulating ubiquitin-specific protease-9.

Chen W, Huang Y, Zhang S, Zheng X, Xie S, Mao J, Cai Y, Lu X, Hu L, Shen J, Dong Y, Chai K. Chen W, et al. J Cell Biochem. 2019 Apr;120(4):6482-6489. doi: 10.1002/jcb.27939. Epub 2018 Oct 18. J Cell Biochem. 2019. PMID: 30335901

8

Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.

Chen W, Zhou Y, Zhi X, Ma T, Liu H, Chen BW, Zheng X, Xie S, Zhao B, Feng X, Dang X, Liang T. Chen W, et al. Biomaterials. 2019 Feb;192:590-600. doi: 10.1016/j.biomaterials.2018.11.035. Epub 2018 Nov 30. Biomaterials. 2019. PMID: 30553134 Free article.

9

Wang X, Song Z, Chen F, Yang X, Wu B, Xie S, Zheng X, Cai Y, Chen W, Zhong Z. Wang X, et al. Am J Transl Res. 2018 Dec 15;10(12):4095-4106. eCollection 2018. Am J Transl Res. 2018. PMID: 30662653 Free PMC article.

10

miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells.

Zhou Y, Chen E, Tang Y, Mao J, Shen J, Zheng X, Xie S, Zhang S, Wu Y, Liu H, Zhi X, Ma T, Ni H, Chen J, Chai K, Chen W. Zhou Y, et al. Cell Death Dis. 2019 Nov 6;10(11):843. doi: 10.1038/s41419-019-2053-8. Cell Death Dis. 2019. PMID: 31695022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters